Pulmonary Hypertension Trial, Recruiting NCT06911632 Sponsor: Tempus AI Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT06911632
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older at the time of signing the consent form
  • People who have already been diagnosed with interstitial lung disease (a group of conditions that cause scarring or inflammation in the lungs)
  • People whose lungs have a reduced ability to transfer oxygen into the blood, measured at a specific low level on a breathing test done within the 3 months before signing the consent form
  • People who are willing and able to give their consent and take part in all study procedures, which may include a heart ultrasound (echocardiogram) and a procedure called a right heart catheterisation (a thin tube inserted to measure pressures in the heart and lungs)

Who may not be able to join:

  • People who have already been diagnosed with pulmonary hypertension (high blood pressure in the lungs), including those who have been prescribed medication specifically for this condition
  • People who have had a right heart catheterisation procedure in the past year, or who already have one scheduled but not yet completed at the time of consent
  • People whose heart's main pumping chamber is found to be significantly weakened (pumping at 40% or less of normal capacity) on their most recent heart scan, if one is available
  • People whose ECG (heart tracing) results, using a specific analysis tool called Tempus PH, cannot be classified after two attempts
  • People for whom the right heart catheterisation procedure is medically unsafe — for example, due to pregnancy or having a mechanical heart valve on the right side of the heart
  • People whose doctor believes that, if directed to have a right heart catheterisation as part of the study, the risks of that procedure would outweigh the potential benefits for them
  • People who have another serious illness that is expected to limit their life expectancy to less than 6 months
  • People who have a medical or personal circumstance that the study doctor believes would make it difficult for them to safely participate in or complete the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (833) 514-4187

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tempus AI
Registry
ClinicalTrials.gov
Start date
23 July 2025
Est. completion
1 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of participants receiving a new diagnosis of PH within the High risk Device group compared to the High risk Control group.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov